American Cyanamid Cyglas 605

Product Description

American Cyanamid Cyglas 605 was an industrial phenolic compound manufactured by American Cyanamid Company, one of the largest chemical and industrial products corporations operating throughout much of the twentieth century. Phenolic compounds in this product category were widely used across heavy industry as binding agents, coatings, adhesives, and composite materials. These formulations were prized for their thermal stability, chemical resistance, and mechanical durability, making them attractive for applications in environments subject to high heat, friction, or corrosive exposure.

American Cyanamid operated as a major supplier of specialty chemical products to industrial customers across multiple sectors. The Cyglas product line represented one segment of the company’s broader catalog of thermosetting resins and molding compounds. Products bearing the Cyglas designation were formulated to meet demanding performance specifications and were distributed to manufacturing facilities, fabrication shops, and industrial processing plants where workers came into regular contact with raw materials, intermediate compounds, and finished components.

The precise years of production for Cyglas 605 have not been uniformly established in publicly available records, though American Cyanamid’s industrial chemical operations spanned decades during the mid-to-late twentieth century, a period when asbestos incorporation into phenolic and thermosetting resin products was a common industry practice. The use of asbestos in such formulations was consistent with broader manufacturing trends of the era, during which asbestos was valued as a reinforcing filler and heat-resistant additive in molded and compounded materials.

Asbestos Content

Litigation records document claims that American Cyanamid Cyglas 605 contained asbestos as a component of its formulated composition. Plaintiffs alleged that asbestos fibers were incorporated into the phenolic resin system, consistent with practices common to the thermosetting compounds industry during periods when asbestos was routinely used as a reinforcing or bulking agent in heat-resistant industrial materials.

Phenolic molding compounds and resin systems of this type frequently employed asbestos — particularly chrysotile and, in some formulations, amphibole varieties — because of the fiber’s ability to impart dimensional stability, thermal resistance, and mechanical strength to the cured product. Plaintiffs alleged that Cyglas 605 followed this established formulation approach, incorporating asbestos in proportions sufficient to confer these material properties.

No publicly available Material Safety Data Sheet or AHERA-governed documentation has been identified for this specific product that would independently confirm the precise asbestos fiber type or percentage by weight. The characterization of the product’s asbestos content in the public record derives primarily from litigation filings, deposition testimony, and related legal proceedings in which former workers and their representatives brought forward claims against American Cyanamid and associated defendants.

How Workers Were Exposed

Litigation records document that industrial workers who handled, processed, or worked in proximity to American Cyanamid Cyglas 605 were potentially exposed to airborne asbestos fibers through multiple pathways inherent to the product’s use in industrial settings.

Workers involved in the handling of raw or uncured phenolic resin compounds faced exposure risks during the measuring, mixing, and transfer of bulk material. Phenolic molding powders and compound intermediates could generate airborne dust during these operations, and where asbestos was present as a filler component, that dust would carry respirable asbestos fibers. Plaintiffs alleged that routine handling of the product in its pre-cured state represented a primary source of occupational fiber release.

Machining, cutting, drilling, grinding, or finishing of cured Cyglas 605 components represented an additional exposure pathway documented in litigation. When thermosetting resin parts containing asbestos were subjected to mechanical processing, the matrix could be disrupted, releasing embedded fibers into the surrounding air. Workers performing these secondary fabrication operations — whether in dedicated machine shops or as part of broader manufacturing lines — were alleged to have inhaled such fibers without adequate protection or warning.

Maintenance and repair work in facilities where Cyglas 605 or components made from it were installed presented further exposure opportunities. Workers replacing worn parts, cleaning equipment surfaces, or disturbing materials that had degraded over time could encounter friable residues containing asbestos.

Industrial workers generally represented the primary exposed population identified in litigation records. This category encompasses a broad range of occupations typical of mid-twentieth century manufacturing environments, including chemical plant operators, compounders, press operators working with molding equipment, machinists, maintenance personnel, and workers in downstream industries that received and fabricated finished components derived from Cyglas 605 resin systems.

Plaintiffs alleged that American Cyanamid was aware, or should have been aware, of the hazards associated with asbestos-containing products during the years these materials were produced and distributed, and that adequate warnings were not provided to downstream workers or employers.

Documented Trust Fund / Legal Options

American Cyanamid Cyglas 605 is a Tier 2 product for purposes of this reference. Legal claims associated with this product have proceeded through the tort litigation system rather than through an established asbestos bankruptcy trust fund, as American Cyanamid has not reorganized under Chapter 11 bankruptcy in a manner that resulted in the creation of a dedicated asbestos settlement trust of the type governed by 11 U.S.C. § 524(g).

Litigation records document that claims related to American Cyanamid asbestos-containing products have been filed in civil courts, with plaintiffs alleging negligence, failure to warn, strict products liability, and related theories of recovery. These claims have been brought by workers diagnosed with asbestos-related diseases including mesothelioma, asbestosis, lung cancer, and other conditions causally associated with occupational asbestos inhalation.

Individuals who believe they were exposed to American Cyanamid Cyglas 605 and have received a diagnosis of an asbestos-related disease should consult with an attorney experienced in asbestos litigation to evaluate the specific facts of their exposure history, the applicable statutes of limitations in their jurisdiction, and the range of potential defendants and recovery avenues relevant to their case.

In some instances, workers exposed to Cyglas 605 may also have had concurrent or subsequent exposure to products from other manufacturers that did establish bankruptcy trusts. An experienced asbestos attorney can identify whether trust fund claims with other defendants may be appropriate in addition to or in lieu of civil litigation targeting American Cyanamid or its corporate successors.

Medical documentation of diagnosis, employment records establishing workplace exposure, and any available product identification evidence are essential components of any claim evaluation. Workers and surviving family members of those who have died from asbestos-related disease are encouraged to preserve and compile such records as early as possible given the time-sensitive nature of legal filings in this area.